title: American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer.
abstract: Transperineal permanent prostate brachytherapy is a safe and efficacious treatment option for patients with organ-confined prostate cancer. Careful adherence to established brachytherapy standards has been shown to improve the likelihood of procedural success and reduce the incidence of treatment-related morbidity. A collaborative effort of the American College of Radiology (ACR) and American Society for Therapeutic Radiation Oncology (ASTRO) has produced a practice guideline for permanent prostate brachytherapy. The guideline defines the qualifications and responsibilities of all the involved personnel, including the radiation oncologist, physicist and dosimetrist. Factors with respect to patient selection and appropriate use of supplemental treatment modalities such as external beam radiation and androgen suppression therapy are discussed. Logistics with respect to the brachytherapy implant procedure, the importance of dosimetric parameters, and attention to radiation safety procedures and documentation are presented. Adherence to these practice guidelines can be part of ensuring quality and safety in a successful prostate brachytherapy program.
authors.affiliation: Radiation Oncology Centers, Radiological Associates of Sacramento, Sacramento, CA 95815-4227, USA. rosenthals@radiological.com
authors.forename: Seth A
authors.initials: SA
authors.lastname: Rosenthal
authors.forename: Nathan H J
authors.initials: NH
authors.lastname: Bittner
authors.forename: David C
authors.initials: DC
authors.lastname: Beyer
authors.forename: D Jeffrey
authors.initials: DJ
authors.lastname: Demanes
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Goldsmith
authors.forename: Eric M
authors.initials: EM
authors.lastname: Horwitz
authors.forename: Geoffrey S
authors.initials: GS
authors.lastname: Ibbott
authors.forename: W Robert
authors.initials: WR
authors.lastname: Lee
authors.forename: Subir
authors.initials: S
authors.lastname: Nag
authors.forename: W Warren
authors.initials: WW
authors.lastname: Suh
authors.forename: Louis
authors.initials: L
authors.lastname: Potters
mesh_terms: D000068:Accreditation; D000726:Androgen Antagonists / Q000627:therapeutic use; D001918:Brachytherapy / Q000379:methods*; D002568:Certification; D003952:Diagnostic Imaging / Q000592:standards; D019983:Guideline Adherence; D006283:Health Physics / Q000193:education / Q000592:standards; D006801:Humans; D008297:Male; D018579:Patient Selection; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011786:Quality Control; D018787:Radiation Oncology / Q000193:education / Q000592:standards*; D011879:Radiotherapy Dosage; D012955:Societies, Medical / Q000592:standards; D013679:Technology, Radiologic / Q000193:education / Q000592:standards; D014481:United States
chemical_list: D000726:Androgen Antagonists